Report Detail

Pharma & Healthcare Global Oxycodone Market Insights, Forecast to 2025

  • RnM3378755
  • |
  • 06 May, 2019
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Oxycodone market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oxycodone market based on company, product type, end user and key regions.

This report studies the global market size of Oxycodone in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oxycodone in these regions.
This research report categorizes the global Oxycodone market by top players/brands, region, type and end user. This report also studies the global Oxycodone market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
Sanofi
Pfizer
Purdue Pharma
Endo International
Teva Pharmaceuticals
Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
Mallinckrodt
Mylan
Sun Pharmaceutical (Chattem Chemicals)
Impax Laboratories
Indivior

Market size by Product
Long Acting Oxycodone
Short Acting Oxycodone
Market size by End User
Hospital Pharmacies
Retail Pharmacies
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Oxycodone market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oxycodone market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oxycodone companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oxycodone submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Oxycodone are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oxycodone market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Oxycodone Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Oxycodone Market Size Growth Rate by Product
      • 1.4.2 Long Acting Oxycodone
      • 1.4.3 Short Acting Oxycodone
    • 1.5 Market by End User
      • 1.5.1 Global Oxycodone Market Size Growth Rate by End User
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Oxycodone Market Size
      • 2.1.1 Global Oxycodone Revenue 2014-2025
      • 2.1.2 Global Oxycodone Sales 2014-2025
    • 2.2 Oxycodone Growth Rate by Regions
      • 2.2.1 Global Oxycodone Sales by Regions
      • 2.2.2 Global Oxycodone Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Oxycodone Sales by Manufacturers
      • 3.1.1 Oxycodone Sales by Manufacturers
      • 3.1.2 Oxycodone Sales Market Share by Manufacturers
      • 3.1.3 Global Oxycodone Market Concentration Ratio (CR5 and HHI)
    • 3.2 Oxycodone Revenue by Manufacturers
      • 3.2.1 Oxycodone Revenue by Manufacturers (2014-2019)
      • 3.2.2 Oxycodone Revenue Share by Manufacturers (2014-2019)
    • 3.3 Oxycodone Price by Manufacturers
    • 3.4 Oxycodone Manufacturing Base Distribution, Product Types
      • 3.4.1 Oxycodone Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Oxycodone Product Type
      • 3.4.3 Date of International Manufacturers Enter into Oxycodone Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Oxycodone Sales by Product
    • 4.2 Global Oxycodone Revenue by Product
    • 4.3 Oxycodone Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Oxycodone Breakdown Data by End User

    6 North America

    • 6.1 North America Oxycodone by Countries
      • 6.1.1 North America Oxycodone Sales by Countries
      • 6.1.2 North America Oxycodone Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Oxycodone by Product
    • 6.3 North America Oxycodone by End User

    7 Europe

    • 7.1 Europe Oxycodone by Countries
      • 7.1.1 Europe Oxycodone Sales by Countries
      • 7.1.2 Europe Oxycodone Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Oxycodone by Product
    • 7.3 Europe Oxycodone by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Oxycodone by Countries
      • 8.1.1 Asia Pacific Oxycodone Sales by Countries
      • 8.1.2 Asia Pacific Oxycodone Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Oxycodone by Product
    • 8.3 Asia Pacific Oxycodone by End User

    9 Central & South America

    • 9.1 Central & South America Oxycodone by Countries
      • 9.1.1 Central & South America Oxycodone Sales by Countries
      • 9.1.2 Central & South America Oxycodone Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Oxycodone by Product
    • 9.3 Central & South America Oxycodone by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Oxycodone by Countries
      • 10.1.1 Middle East and Africa Oxycodone Sales by Countries
      • 10.1.2 Middle East and Africa Oxycodone Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Oxycodone by Product
    • 10.3 Middle East and Africa Oxycodone by End User

    11 Company Profiles

    • 11.1 Johnson & Johnson
      • 11.1.1 Johnson & Johnson Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Johnson & Johnson Oxycodone Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Johnson & Johnson Oxycodone Products Offered
      • 11.1.5 Johnson & Johnson Recent Development
    • 11.2 Sanofi
      • 11.2.1 Sanofi Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi Oxycodone Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi Oxycodone Products Offered
      • 11.2.5 Sanofi Recent Development
    • 11.3 Pfizer
      • 11.3.1 Pfizer Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Pfizer Oxycodone Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Pfizer Oxycodone Products Offered
      • 11.3.5 Pfizer Recent Development
    • 11.4 Purdue Pharma
      • 11.4.1 Purdue Pharma Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Purdue Pharma Oxycodone Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Purdue Pharma Oxycodone Products Offered
      • 11.4.5 Purdue Pharma Recent Development
    • 11.5 Endo International
      • 11.5.1 Endo International Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Endo International Oxycodone Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Endo International Oxycodone Products Offered
      • 11.5.5 Endo International Recent Development
    • 11.6 Teva Pharmaceuticals
      • 11.6.1 Teva Pharmaceuticals Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Teva Pharmaceuticals Oxycodone Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Teva Pharmaceuticals Oxycodone Products Offered
      • 11.6.5 Teva Pharmaceuticals Recent Development
    • 11.7 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
      • 11.7.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Products Offered
      • 11.7.5 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Development
    • 11.8 Mallinckrodt
      • 11.8.1 Mallinckrodt Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Mallinckrodt Oxycodone Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Mallinckrodt Oxycodone Products Offered
      • 11.8.5 Mallinckrodt Recent Development
    • 11.9 Mylan
      • 11.9.1 Mylan Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Mylan Oxycodone Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Mylan Oxycodone Products Offered
      • 11.9.5 Mylan Recent Development
    • 11.10 Sun Pharmaceutical (Chattem Chemicals)
      • 11.10.1 Sun Pharmaceutical (Chattem Chemicals) Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Products Offered
      • 11.10.5 Sun Pharmaceutical (Chattem Chemicals) Recent Development
    • 11.11 Impax Laboratories
    • 11.12 Indivior

    12 Future Forecast

    • 12.1 Oxycodone Market Forecast by Regions
      • 12.1.1 Global Oxycodone Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Oxycodone Revenue Forecast by Regions 2019-2025
    • 12.2 Oxycodone Market Forecast by Product
      • 12.2.1 Global Oxycodone Sales Forecast by Product 2019-2025
      • 12.2.2 Global Oxycodone Revenue Forecast by Product 2019-2025
    • 12.3 Oxycodone Market Forecast by End User
    • 12.4 North America Oxycodone Forecast
    • 12.5 Europe Oxycodone Forecast
    • 12.6 Asia Pacific Oxycodone Forecast
    • 12.7 Central & South America Oxycodone Forecast
    • 12.8 Middle East and Africa Oxycodone Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Oxycodone Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Global Oxycodone . Industry analysis & Market Report on Global Oxycodone is a syndicated market report, published as Global Oxycodone Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Global Oxycodone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,065.40
      4,598.10
      6,130.80
      3,599.70
      5,399.55
      7,199.40
      612,339.00
      918,508.50
      1,224,678.00
      324,129.00
      486,193.50
      648,258.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report